F
Fabrice Barlesi
Researcher at Aix-Marseille University
Publications - 666
Citations - 36214
Fabrice Barlesi is an academic researcher from Aix-Marseille University. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 64, co-authored 582 publications receiving 25403 citations. Previous affiliations of Fabrice Barlesi include Institut Gustave Roussy & Nord University.
Papers
More filters
Journal ArticleDOI
1070P Previous viral infections assessed by pan-virus phage immunoprecipitation sequencing (PhIP-Seq) predict response to immune checkpoint blockers (ICBs) in non-small cell lung cancer (NSCLC)
Filippo Gustavo Dall'Olio,Marvin Lerousseau,G. Roman,François-Xavier Danlos,Mihaela Aldea,Nathalie Chaput-Gras,David Planchard,Fabrice Barlesi,Tyler W. Hulett,Aurélien Marabelle,Benjamin Besse +10 more
TL;DR: In this paper , the potential implications of antibody response to previous viral infections in predicting the response to ICBs in NSCLC patients were revealed, which revealed the potential impact of previous viral infection on ICB efficacy.
Journal ArticleDOI
Utilisation des tests génomiques en oncologie : avis d’experts Français selon la méthode Delphi
TL;DR: In this paper , a national consensus approach based on a modified Delphi methodology was set up to provide expert opinion on the use of genome-wide testing in clinical practice in France, and four groups of experts -4 each representing the following topics of interest -were defined: non-small cell lung cancer (NSCLC), breast cancer, melanoma, and cancer of unknown primary (CUP).
Journal ArticleDOI
La surrénalectomie améliore la survie de patients sélectionnés porteurs d’un cancer oligométastatique
TL;DR: La surrenalectomie fait partie de the prise en charge des patients porteurs de cancers oligometastatiques mais ceux-ci doivent etre selectionnes.
Journal ArticleDOI
Stereotactic body radiotherapy for extra-cranial oligoprogressive or oligorecurrent small-cell lung cancer
Antonin Levy,Jonathan Khalifa,Etienne Martin,Angela Botticella,C. Quevrin,Pernelle Lavaud,Mihaela Aldea,Benjamin Besse,David Planchard,Fabrice Barlesi,Eric Deutsch,C. Massabeau,Jérôme Doyen,Cécile Le Péchoux +13 more
TL;DR: The role of local ablative treatments, including stereotactic body radiotherapy (SBRT), is an area of active research in oligometastatic patients as discussed by the authors , where the authors evaluated the outcomes after SBRT in uncommon oligoprogressive/oligorecurrent SCLC presentation.
Journal ArticleDOI
P3-220: Pulmonary function tests as a predictor of quantitative and qualitative outcomes after thoracic surgery for lung cancer
Laurent Greillier,Pascal Thomas,Anderson Loundou,Christophe Doddoli,Karine Barrau,Monique Badier,Pascal Auquier,Fabrice Barlesi +7 more
TL;DR: Pulmonary function tests allow a relatively good prediction of postoperative quantitative outcomes such as postoperative morbidity and mortality as well as OS after thoracic surgery for NSCLC, however, pulmonary function tests remain poorly correlated to postoperative qualitative outcomes, making QOL a separate and essential assessment of the health status of patients with resected NSClC.